Individual needs vary based on dietary intake, baseline nutritional status, and degree of weight loss, making personalized assessment essential for optimal outcomes
doses entre 5 e 10 mg por dia
Medical Writing/Editorial Assistance The authors acknowledge Mathias Hempfling, MSc, from Costello Medical Consulting, Cambridge, UK for medical writing and editorial assistance in preparing this manuscript for publication based on the authors input and direction
Novo Nordisk and Lilly are especially competitive players because of the oral obesity drugs as an extension of the incretin therapy trend, while Roche can benefit from its participation in the existing oral anti-obesity drugs market
It is a signal that deserves clinical attention, whether the cause is hormonal, neurochemical, nutritional, or some combination
The Importance of Medical Supervision The question of whether GLP-1s cause kidney stones underscores the importance of a medically supervised weight loss journey